This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: The Innovations of Stephane Demotz
Introduction
Stephane Demotz is a notable inventor based in Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative treatments for genetic disorders, showcasing his commitment to advancing medical science.
Latest Patents
Stephane Demotz holds a patent titled "Preparation Of Isolated Agonist Anti-Edar Monoclonal Antibodies." This invention concerns the preparation of substantially purified agonist anti-EDAR monoclonal antibodies or isolated monoclonal antibody fragments. The invention also relates to their use in treating X-linked hypohidrotic ectodermal dysplasia and tooth agenesis. Furthermore, it includes a pharmaceutical composition comprising these isolated antibodies and a method for treating the aforementioned conditions.
Career Highlights
Throughout his career, Demotz has worked with esteemed institutions such as Université de Lausanne and Espoirxlhed Sarl. His experience in these organizations has allowed him to collaborate with leading experts in the field, enhancing his research and development capabilities.
Collaborations
Some of his notable coworkers include Pascal Schneider and Nathalie Dunkel. Their collaborative efforts have contributed to the advancement of his research projects and innovations.
Conclusion
Stephane Demotz is a dedicated inventor whose work in monoclonal antibodies has the potential to impact the treatment of genetic disorders significantly. His innovative spirit and collaboration with esteemed colleagues highlight his contributions to the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile